VentriPoint Diagnostics Balance Sheet Health
Financial Health criteria checks 5/6
VentriPoint Diagnostics has a total shareholder equity of CA$1.3M and total debt of CA$141.4K, which brings its debt-to-equity ratio to 10.8%. Its total assets and total liabilities are CA$2.9M and CA$1.6M respectively.
Key information
10.8%
Debt to equity ratio
CA$141.44k
Debt
| Interest coverage ratio | n/a |
| Cash | CA$2.30m |
| Equity | CA$1.31m |
| Total liabilities | CA$1.60m |
| Total assets | CA$2.92m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 5V7's short term assets (CA$2.7M) exceed its short term liabilities (CA$1.3M).
Long Term Liabilities: 5V7's short term assets (CA$2.7M) exceed its long term liabilities (CA$315.5K).
Debt to Equity History and Analysis
Debt Level: 5V7 has more cash than its total debt.
Reducing Debt: 5V7's debt to equity ratio has increased from 0% to 10.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 5V7 has sufficient cash runway for 7 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: 5V7 is forecast to have sufficient cash runway for 6 months based on free cash flow estimates, but has since raised additional capital.